Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.
about
The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.Anti-Müllerian hormone levels in patients with gestational trophoblastic neoplasia treated with different chemotherapy regimens: a prospective cohort study.Gonadotropin-releasing hormone analogs for ovarian function protection during chemotherapy in young early breast cancer patients: the last piece of the puzzle?Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recoveryDeterminants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial
P2860
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Prospective evaluation of seru ...... hemotherapy for breast cancer.
@en
type
label
Prospective evaluation of seru ...... hemotherapy for breast cancer.
@en
prefLabel
Prospective evaluation of seru ...... hemotherapy for breast cancer.
@en
P2093
P1476
Prospective evaluation of seru ...... chemotherapy for breast cancer
@en
P2093
A Dezellus
A Gallais-Umbert
C Bendavid
C Jouannaud
C Lemanski
C Loustalot
M A Mouret-Reynier
P356
10.1016/J.EJCA.2017.03.035
P577
2017-04-29T00:00:00Z